Here are four biotechs to consider, two of which are involved in developing drugs to fight the Ebola virus.
As the broad market has been breaking down, these four stocks have taken hits. Technical analysis suggests they're likely to fall further.
Two of these stocks are for the long term while two could provide shorting opportunities in a selloff.
three four to watch for more upside.
A lot of stocks we follow closely are doing very well, and here are four to watch for continued upside.
A lot of stocks we follow continued strong on Thursday, and here are four that appear to have more room to run.
There are some attractive charts on both the long and short side.
bioCryst Pharmaceuticals and Arris Enterprises also appear to have more room to run.
Here are four stocks in strong uptrends, at or near key breakout levels with more room to run.
A lot of our stocks did well on Monday, and here are some of the more interesting charts to watch.